1 2 3 4 5

Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1–hepatitis C...

Griesbeck, Morgane; Valantin, Marc-Antoine; Lacombe, Karine; More

AIDS . 31(9):1223-1234, June 1, 2017.

Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir

Calin, Ruxandra; Hamimi, Chiraz; Lambert-Niclot, Sidonie; More

AIDS . 30(5):761-769, March 13, 2016.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

Katlama, Christine; Lambert-Niclot, Sidonie; Assoumou, Lambert; More

AIDS . 30(2):221-230, January 2016.

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

Guihot, Amélie; Dentone, Chiara; Assoumou, Lambert; More

AIDS . 30(2):327-330, January 2016.

Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia

Campillo-Gimenez, Laure; Assoumou, Lambert; Valantin, Marc-Antoine; More

AIDS . 29(7):853-856, April 24, 2015.

Increased carotid intima–media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients

Goulenok, Tiphaine; Boyd, Anders; Larsen, Martin; More

AIDS . 29(3):287-293, January 28, 2015.

Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers

de Masson, Adèle; Kirilovsky, Amos; Zoorob, Rima; More

AIDS . 28(11):1567-1577, July 17, 2014.

The link between CD8+ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate

Lissina, Anna; Fastenackels, Solène; Inglesias, Maria C.; More

AIDS . 28(4):477-486, February 20, 2014.

MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection

Antoni, Guillemette; Guergnon, Julien; Meaudre, Céline; More

AIDS . 27(11):1707-1716, July 17, 2013.

Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients

Appay, Victor; Fastenackels, Solène; Katlama, Christine; More

AIDS . 25(15):1813-1822, September 24, 2011.

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine

Papagno, Laura; Alter, Galit; Assoumou, Lambert; More

AIDS . 25(1):27-36, January 2, 2011.

Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients

Canestri, Ana; Krivine, Anne; Assoumou, Lambert; More

AIDS . 24(18):2887-2889, November 27, 2010.

Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control

Xie, Jing; Lu, Wei; Samri, Assia; More

AIDS . 24(15):2323-2329, September 24, 2010.

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy

Guihot, Amélie; Tubiana, Roland; Breton, Guillaume; More

AIDS . 24(4):614-617, February 20, 2010.

Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus

Schnuriger, Aurélie; Dominguez, Stéphanie; Guiguet, Marguerite; More

AIDS . 23(16):2079-2089, October 23, 2009.

Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells

Lécuroux, Camille; Girault, Isabelle; Boutboul, François; More

AIDS . 23(13):1649-1658, August 24, 2009.

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

Bénard, Antoine; Damond, Florence; Campa, Pauline; More

AIDS . 23(9):1171-1173, June 1, 2009.

Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)

Autran, Brigitte; Murphy, Robert L; Costagliola, Dominique; More

AIDS . 22(11):1313-1322, July 11, 2008.

Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity

Braibant, Martine; Brunet, Sylvie; Costagliola, Dominique; More

AIDS . 20(15):1923-1930, October 3, 2006.

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

Bourgarit, Anne; Carcelain, Guislaine; Martinez, Valerie; More

AIDS . 20(2):F1-F7, January 9, 2006.

Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV

Boutboul, François; Puthier, Denis; Appay, Victor; More

AIDS . 19(17):1981-1986, November 18, 2005.

IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia

Carcelain, Guislaine; Saint-Mézard, Pierre; Altes, Hester Korthals; More

AIDS . 17(6):841-850, April 11, 2003.

Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection

Chouquet, Cécile; Autran, Brigitte; Gomard, Elisabeth; More

AIDS . 16(18):2399-2407, December 6, 2002.

Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study – ANRS 082

Katlama, Christine; Carcelain, Guislaine; Duvivier, Claudine; More

AIDS . 16(15):2027-2034, October 18, 2002.

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure

Delaugerre, Constance; Valantin, Marc-Antoine; Mouroux, Mireille; More

AIDS . 15(16):2189-2191, November 9, 2001.

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection

Ruiz, Lidia; Carcelain, Guislaine; Martínez-Picado, Javier; More

AIDS . 15(9):F19-F27, June 15, 2001.

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy

Jouan, Marc; Savès, Marianne; Tubiana, Roland; More

AIDS . 15(1):23-31, January 5, 2001.

T cell changes after combined nucleoside analogue therapy in HIV primary infection

Carcelain, Guislaine; Blanc, Catherine; Leibowitch, Jacques; More

AIDS . 13(9):1077-1081, June 18, 1999.

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen

Renaud, Marc; Katlama, Christine; Mallet, Alain; More

AIDS . 13(6):669-676, April 16, 1999.

1 2 3 4 5